First interventional exchange of a left transvenous phrenic nerve stimulation lead from the novel remedē system

J Cardiovasc Electrophysiol. 2020 Nov;31(11):3056-3060. doi: 10.1111/jce.14725. Epub 2020 Sep 1.

Abstract

The remedē system is a novel fully implantable transvenous phrenic nerve stimulation (TPNS) device developed to treat central sleep apnea. No information is published on how to explant or replace its leads. An eighty-one year-old had a fractured lead and we removed it over a wire. However, unbreachable resistances occurred with a new lead deployed over the enclosed wire and interventional endovascular techniques were performed to reimplant a new fully functioning system. This first report demonstrates TPNS lead exchange is possible but can be challenging. Interventional maneuvers and techniques, including balloon angioplasty, can facilitate this procedure.

Keywords: central sleep apnea; heart failure; lead exchange; lead extraction; lead fracture; phrenic nerve stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Electric Stimulation Therapy*
  • Humans
  • Phrenic Nerve
  • Sleep Apnea, Central* / therapy
  • Treatment Outcome